PACB
HEALTHCAREPacific Biosciences of California Inc
$1.71+0.13 (+8.23%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PACB Today?
No stock-specific AI insight has been generated for PACB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.85$2.73
$1.71
Fundamentals
Market Cap$531M
P/E Ratio—
EPS$-1.83
Dividend Yield—
Dividend / Share—
ROE-2.1%
Profit Margin—
Debt / Equity—
Trading
Volume7.5M
Avg Volume (10D)—
Shares Outstanding310.5M
PACB News
24 articles- [10-Q] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Earnings ReportStock Titan·May 9, 2026
- PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin DownYahoo Finance·May 8, 2026
- Pacific Biosciences of California, Inc. Q1 2026 Earnings Call SummaryMoby·May 8, 2026
- Pacific Biosciences of California Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 7, 2026
- PacBio (NASDAQ:PACB) Misses Q1 CY2026 Sales ExpectationsYahoo Finance·May 7, 2026
- PacBio Announces First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?Yahoo Finance·May 5, 2026
- OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·Apr 30, 2026
- Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should KnowYahoo Finance·Apr 29, 2026
- Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsightGlobeNewswire Inc.·Apr 29, 2026
- Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FGlobeNewswire Inc.·Apr 24, 2026
- Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for InvestorsYahoo Finance·Apr 22, 2026
- PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read SequencingYahoo Finance·Apr 21, 2026
- GEHC & DeepHealth Advance AI Breast Cancer Screening GloballyYahoo Finance·Apr 20, 2026
- Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To KnowYahoo Finance·Apr 18, 2026
- PacBio Stock Up on New FFPE Workflow Boosting Cancer SequencingYahoo Finance·Apr 17, 2026
- STXS to Acquire Robocath to Lead in Endovascular Robotics MarketYahoo Finance·Apr 17, 2026
- PacBio to Report First Quarter 2026 Financial Results on May 7, 2026Yahoo Finance·Apr 16, 2026
- Here's Why You Should Add DexCom Stock to Your Portfolio NowYahoo Finance·Apr 16, 2026
- Reasons to Retain West Pharmaceutical Stock in Your Portfolio for NowYahoo Finance·Apr 16, 2026
- Glaukos Wins Permanent J-Code for Epioxa Keratoconus TherapyYahoo Finance·Apr 16, 2026
- Why Pacific Biosciences of California (PACB) Outpaced the Stock Market TodayYahoo Finance·Apr 15, 2026
- Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical ApplicationsGlobeNewswire Inc.·Apr 7, 2026
All 24 articles loaded
Price Data
Open$1.58
Previous Close$1.58
Day High$1.70
Day Low$1.58
52 Week High$2.73
52 Week Low$0.85
52-Week Range
$0.85$2.73
$1.71
Fundamentals
Market Cap$531M
P/E Ratio—
EPS$-1.83
Dividend Yield—
Dividend / Share—
ROE-2.1%
Profit Margin—
Debt / Equity—
Trading
Volume7.5M
Avg Volume (10D)—
Shares Outstanding310.5M
About Pacific Biosciences of California Inc
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to solve genetically complex problems. The company is headquartered in Menlo Park, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—